# NAPO - Novel Approach for Oligospermia

> **NCT06300229** · PHASE1,PHASE2 · COMPLETED · sponsor: **Martin Blomberg Jensen** · enrollment: 42 (actual)

## Conditions studied

- Infertility, Male

## Interventions

- **DRUG:** Denosumab
- **DRUG:** sodium chloride

## Key facts

- **NCT ID:** NCT06300229
- **Lead sponsor:** Martin Blomberg Jensen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-01
- **Primary completion:** 2025-01-29
- **Final completion:** 2025-08-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06300229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06300229, "NAPO - Novel Approach for Oligospermia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06300229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*